Obama calls for second chances, lighter sentences
A bipartisan movement to cut prison sentences for nonviolent drug crimes and make it easier for ex-offenders to find employment could get caught up it presidential politics.
Bloomberg News
Articles
FanDuel sued by former Colt over use of name, image
Pierre Garcon, who now plays for the Washington Redskins, and his lawyers accused the Manhattan-based FanDuel of exploiting him and other National Football League players to grow its business.
Big insurers remain upbeat about fledgling ACA exchanges
Slipping enrollment has done little to shake the faith that the nation's biggest health insurers, including Anthem, have placed in the Affordable Care Act's public insurance exchanges.
Elanco president makes case for juiced-up cows in organic age
Jeff Simmons is on a counteroffensive as, increasingly, the drugs that Elanco makes—including antibiotics and productivity enhancers—have come under attack by food activists.
Anthem shares fall as Obamacare slump weighs on outlook
Shares in Anthem Inc., the nation's third-largest health insurer by market value, dropped Wednesday after the company’s 2015 profit outlook fell short of estimates.
EPA’s clean-power initiative under renewed attack by states
The regulatory package known as the Clean Power Plan officially became U.S. law Friday. It was immediately challenged by 24 states in a U.S. appeals court filing that included Indiana.
Obama officials resist call to release mortgage giants
The U.S. owns nearly 80 percent of Fannie Mae and Freddie Mac, and investors have been pressing the administration to unwind a 2012 decision to sweep their profits to the Treasury Department.
Anthem shares sliding after Clinton calls for merger review
Shares in Anthem Inc. and Cigna Corp., which agreed to a $48 billion deal in July, continued to slide Thursday after presidential candidate Hillary Clinton said mergers in the industry deserve more scrutiny.
Pharmaceutical firms losing business to darknet drug deals
For the $300 billion pharmaceutical industry, the rapid growth of illegal underground marketplaces is a serious threat to profits and reputations.
Supreme Court could weigh in on student debt battle
The lawsuit asks the court to clarify 1970s-era rules that prevent borrowers from getting rid of education debt in bankruptcy, except in cases in which repaying it would constitute an “undue hardship.”
Lilly competitor fails to win FDA backing for diabetes treatment
AstraZeneca Plc didn’t receive U.S. approval for a new diabetes treatment that combines two of its existing drugs. The combination would have competed with Glyxambi from Lilly.
Southwest fixes computer failure, sees normal flight schedule
Southwest Airlines Co. said it has fixed computer system failures that delayed hundreds of flights around the United States over the weekend.
UPDATE: Lilly halts work on potential blockbuster cholesterol drug
Eli Lilly shares plunged nearly 10 percent Monday morning after it said it would stop development of evacetrapib, an experimental cholesterol drug with blockbuster potential.
Lilly expands China drug partnership in growing cancer market
Suzhou, China-based Innovent could receive payments totaling more than $1 billion if the cancer products it develops with Lilly reach certain milestones.
Obama travels narrow road toward trade-pact approval
President Barack Obama needs to hold together a razor-thin majority of pro-trade lawmakers in the U.S. Congress to win approval of his huge Asia-Pacific trade deal.
Delta sues Republic Airways over flights lost to pilot dispute
Indianapolis-based Republic has been unable to fulfill an unspecified number of flights for Delta’s regional operation, Delta Connection, according to the suit filed Monday.
Butler called lone exception to ‘Field of Dreams’ approach
Building or investing in sports facilities in order to boost finances at a university is nearly always a losing play, according to financial experts.
NCAA athletes face long next yard in bid for free-market pay
College athletes are heading back to court in pursuit of pay for play one day after a major setback in their quest for a larger share of the multibillion-dollar industry.
Mall owner that spurned Simon takeover makes $2.3B deal
Macerich Co. has agreed to sell minority stakes in eight U.S. malls for $2.3 billion to Singapore’s GIC Pte and property investor Heitman LLC.
Puerto Rico plans new corporate tax to replace excise levy
Puerto Rico officials are looking to replace an expiring tax with a new levy to draw much-needed revenue from the world’s best-selling medications while seeking to avoid driving U.S. manufacturers such as Eli Lilly and Co. from the commonwealth.